Profit before exceptional items and tax fell 23.66% YoY to Rs 100 crore in Q2 FY27. The company reported exceptional items of Rs 14 crore during the quarter.

The Crop Care business recorded topline growth of 4%, primarily driven by 17% growth in the B2B segment with a strong recovery in custom synthesis and manufacturing (CSM) portfolio.

The domestic formulations (B2C) business remained flat YoY, despite 16% growth in herbicides, while insecticide sales remained unchanged. The Soil & Plant Health (SPH) business registered 22% growth, primarily driven by higher prices.

During the quarter, the company launched four new products in Crop Care category, Silentra (Insecticide), Marcellus (Fungicide), Blitox Super (Fungicide) and Trynage (Herbicide). The new products cater to critical crop-pest segments like Rice BPH and sheath blight segments, sugarcane herbicide and disease control in key horticulture crop.

The Seeds business recorded a decline, primarily due to higher returns from the Kharif season.

The company’s management commented that weather-related disruptions and delayed sowing continued to impact market demand during the quarter/season. We remain focused on improving market execution, driving cost efficiencies and strengthening customer engagement to navigate these challenges and enhance business performance.

For the half-year ended 30 September 2026, the company's standalone revenue stood at Rs 1,880 crore, up 3.41% from Rs 1,818 crore in H1 FY26. EBITDA increased 2.30% YoY to Rs 311 crore in H1 FY27, compared with Rs 304 crore in H1 FY26. Profit after tax (PAT) rose 6.60% YoY to Rs 210 crore from Rs 197 crore in the corresponding period last year.

Rallis India, a Tata Group company, has a history of over 150 years. The company is into the manufacturing of agrochemicals and is present across the value chain of agricultural inputs from seeds to organic plant growth nutrients. Rallis is also in the business of contract manufacturing for global corporations.